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Abstract 
Hepatitis C (HCV) is a blood borne virus that affects the liver. It has become 
one of the most widespread blood borne viruses in Australia, now reaching epidemic 
proportions within the population. Given that HCV is a chronic long-term illness, with 
long term effects, a positive diagnosis potentially impacts on various aspects of a 
person's life. The aim of this paper was to review HCV related research to examine 
what it is like for people living with the virus and the possible personal and social 
impacts of a positive diagnosis. The nature of HCV, including current incidence and 
prevalence rates, natural history, transmission and treatment are discussed. Recent 
quantitative and qualitative research focusing on the various impacts of hepatitis C and 
the subsequent effects on quality of life are then critically explored. While formal 
research in this area is relatively limited, the available evidence suggests that 
individuals living with HCV experience a wide range of personal and social impacts, 
resulting in a significant decline in quality of life. The need for further understanding of 
this serious public health issue is discussed and possible directions for future research 
are identified. 
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Living With Hepatitis C : A Literature Review 
1. Introduction 
Since it's identification in 1989, hepatitis C has become one of the most 
widespread blood-borne viruses throughout Australia (Department of Health and Aged 
Care (DHAC), 2000). It is thought that the hepatitis C virus (HCV) has existed since 
the early 1970s, but was known only as 'non A - non B' hepatitis for approximately 
twenty years (Standing Committee on Social Issues (SCSI), 1998). The nature of the 
hepatitis C virus is unique in that there is a considerable lag between the time of 
infection and the onset of consequences (SCSI, 1998). Therefore, the seriousness of the 
virus and the extent to which it affects the population is only just beginning to be 
recognised. It is now understood that hepatitis C has reached epidemic proportions and 
has become a major public health issue in Australia (DHAC, 2000). 
While there has been a large amount of research on the epidemiology (Dolan, 
2000; Dore, 2000a), prevention (Wodak & Crofts, 1996) and treatment (Sievert & 
Korevaar, 1999) of hepatitis C, relatively few studies have documented the extent to 
which a positive diagnosis impacts on various aspects of a person's life (Garrett & 
Conrad, 2001; Burrows & Bassett, 1996; Crofts, Louie & Loff, 1997). Hepatitis C is a 
chronic illness for the majority of people, thus in order to provide adequate care and 
support, it is imperative to understand the meaning that a positive diagnosis has for the 
person (Lin, Barker & Batey, 1999; Loveday, Deakin & Neophyton, 1999). 
Furthermore, while it is important to understand how the medical aspect of the virus 
affects the person, the emotional, psychological and social components also need to be 
acknowledged (Hepworth & Krug, 1999; Strauss, Corbin, Fagerhaugh, Glaser, Maines, 
Suczek & Wiener, 1984). 
This paper is a review of the literature relevant to hepatitis C and the possible 
personal and social impacts of a positive diagnosis. Firstly, a profile of hepatitis C, 
including, current incidence and prevalence rates, natural history, transmission and 
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treatment will be discussed. Research focusing on the various impacts of hepatitis C 
and the subsequent effects on quality oflife will then be critically explored. Finally, 
gaps in the literature will be identified and future directions for research will be 
acknowledged. 
2. Hg,atitis C: A Profile of the Virus 
Hepatitis means inflammation of the liver, which can cause damage to liver cells 
(Hepatitis C Council of WA (HCCWA), 1998). There are several different causes of 
hepatitis, including chemicals, alcohol, drugs, impaired immune systems and viral 
infections such as hepatitis A (HAV), hepatitis B (HBV) and hepatitis C (HCV) 
(DHAC, 2000; HCCWA, 1998). A laboratory test for hepatitis C has been available 
since 1990 and it has since been discovered that there are at least nine different strains 
ofHCV with which people can become co-infected (Australian National Council on 
AIDS and Related Diseases (ANCARD), 1998; DHAC, 2000; HCCW A, 1998). 
Currently there is no vaccine available for hepatitis C so for many people the virus is a 
life long condition (Lowe & Cotton, 1 999). 
2.1 Prevalence and Incidence 
Prevalence refers to the total number of people in a population who have the 
virus at a specific point in time (SCSI, 1 998). Current estimates suggest that over 
200,000 people have been infected with hepatitis C in Australia (DHAC, 2000; 
ANCARD, 1998). Prevalence has also been cited as approximately 1 % of the 
population which equates to one person in every 100, being HCV positive (HCCW A, 
1998). The Hepatitis C Sub-Committee suggest that if current transmission rates 
continue, prevalence figures are likely to double by the year 2010  (AN CARD, 1998). 
Incidence refers to the number of people who are newly infected with hepatitis 
C each year and reflects the rate at which the disease occurs (DHAC, 2000). Current 
estimates of incidence rates suggest that approximately 1 1 ,000 new HCV infections 
occur each year (DHAC, 2000). Since the screening of blood supplies in 1990, 
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approximately 90% of these new infections are believed to be from injecting drug use 
(Lowe & Cotton, 1999; ANCARD, 1998). 
In many respects hepatitis C is a relatively new virus, which is reflected by the 
difficulty in obtaining accurate figures on the prevalence and incidence of the disease 
(SCSI, 1998). Prevalence studies to date have obtained data by screening selected sub­
groups, none of which can be described as a representative sample of the general 
community (ANCARD, 1998). Instead, the prevalence of hepatitis C has been 
estimated in sub-populations including injecting drug users (Selvey, Denton & Plant, 
1997; Wodak & Crofts, 1996), blood donors (Archer et al., 1992) and prisoners (Dolan, 
2000). 
Most prevalence studies of hepatitis C amongst injecting drug users have 
reported consistent rates of 50% - 70% since the 1970's (ANCARD, 1998), however 
some studies have reported figures as high as 94% (Gaughwin, Dodding & Ali, 1994). 
Blood donors have much lower prevalence rates, with an average of 1 % of the 
population testing positive for hepatitis C (ANCARD, 1998). Studies within prisons 
have reported higher prevalence rates of approximately 35% amongst general prisoners 
and up to 80% amongst prisoners who are also injecting drug users (Dolan, 2000). 
It is acknowledged that a number of methodological problems associated with 
HCV epidemiology means that estimated prevalence and incidence rates should be 
interpreted with caution (Lowe & Cotton, 1999). There are limitations with current 
testing technology in that tests do not distinguish between acute, newly acquired 
infections and chronic, long-term infections (DHAC, 2000). Therefore, accurate and 
reliable data concerning incidence rates of hepatitis C in Australia are very difficult to 
estimate (ANCARD, 1998). Furthermore, due to the absence of representative 
population based information, it is still uncertain about the actual number of people who 
are HCV positive (SCSI, 1998). Despite numerous studies of hepatitis C within specific 
populations, it is clear that research is still needed to monitor prevalence and incidence 
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within the general community if a clearer picture of the epidemic is to evolve (SCSI, 
1 998). 
2.2 Natural History of Hepatitis C 
It has been noted that hepatitis C attacks and damages liver cells, however the 
extent of damage and the natural history of the disease can vary between people 
(HCCWA, 1998). The initial phase of infection is described as acute hepatitis C which 
occurs approximately 6 to 10  weeks after exposure and usually lasts between 2 and 6 
months (Marinos, Piro la & Locarnini, 1999). During this time levels of the virus are 
high, however acute hepatitis C appears to be symptomatic in only 25% of cases, so 
most of the time the acute phase goes unnoticed (Marinos, Pirola & Locamini, 1 999; 
HCCWA, 1998). 
Although the body produces antibodies to fight the virus, it is not eliminated in 
the majority of cases and the infection becomes chronic (HCCW A, 1998). Chronic 
hepatitis C infection is defined as persisting for more than six months and refers 
specifically to the duration of the virus and not the severity of the disease (Lin, Barker 
& Batey, 1 999). Chronic hepatitis C infection can lead to a wide spectrum of liver 
disease ranging from various levels of damage through to cirrhosis ( scarring of the 
liver), however HCV is a very slow acting virus and can take up to 30 years to cause 
damage (Lin, Barker & Batey, 1999). 
In a recent review of studies concerning the natural history of hepatitis C, Dore 
(2000a) reported the following outcomes if 100 people were infected with the virus. 
Approximately 15  to 35 people will clear the virus within 2 to 6 months of infection, 
thus only experiencing the acute phase of hepatitis C. However, clearance of the virus 
does not lead to immunity and these people can be re-infected if they are subsequently 
exposed to the virus. The remaining 65 to 85 people will not eliminate the virus and 
will develop chronic hepatitis C infection. Some of these people will never develop any 
liver damage and others will experience some level of damage after an average of 13 
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years (HCCWA, 1998). It is believed that of the people who develop chronic HCV 
infection, 5 to 10  will have progressed to cirrhosis after an average of twenty years, 
with increased risk for those with sufficient alcohol consumption or co-infection with 
HIV or hepatitis B. About 3 to 5 people with hepatitis C related cirrhosis will be at risk 
of liver failure or hepatocellular carcinoma (HCC) after thirty to forty years of infection. 
One of the difficulties in predicting the progression of hepatitis C, is that once 
chronic infection has been established, the course of the virus appears to differ 
enormously among individuals (Dore, 2000a). Furthermore, the factors that influence 
clearance ofHCV or the progression to cirrhosis or advanced liver disease are not 
clearly understood (Dore, 2000a; AN CARD, 1 999). The lack of clinical illness for the 
majority of people with newly acquired HCV means that most people do not know they 
are infected, resulting in a small sample of cases and limited follow-up in many studies 
ofHCV progression (Dore, 2000a). 
It is also acknowledged that a major limitation of natural history studies is that 
most of the data comes from those who have acquired their infection via blood 
transfusions (Dore, 2000a; ANCARD, 1999). It is possible that the progression of 
hepatitis C may be different in those who have post transfusion infection as opposed to 
the more common community-acquired infection (injecting drug use) (ANCARD, 
1999). Therefore, as most hepatitis C infections in Australia are a result of injecting 
drug use, research on the natural history of the virus may be invalid (Dore, 2000a). 
Dore (2000a) also notes that a large number of studies are conducted on selective clinic­
based groups such as liver clinics, suggesting there needs to be more data made 
available from representative population based research. 
2.3 Transmission 
Hepatitis C is a blood-borne virus that requires blood-to-blood contact for 
infection to occur (HCCWA, 1998). It is relatively robust and only minute amounts of 
blood are needed to infect someone, during both the acute or chronic phases of the virus 
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(HCCWA, 1998). Studies of hepatitis C risk factors have suggested that around 80% of 
people that are positively diagnosed in Australia, were exposed through injecting drug 
use (Dore, Pritchard-Jones, Fisher & Law, 1999; ANCARD, 1998). Approximately 7% 
acquired hepatitis C through the receipt of blood or blood products, and 13% were 
infected via other routes such as tattoos and needlestick injuries (ANCARD, 1998). 
The various routes through which hepatitis C is transmitted will now be examined 
further. 
2.3.1. Injecting drug use. 
Sharing needles and syringes, as well as other drug injecting equipment 
including water, swabs and spoons, poses the highest risk of transmitting or acquiring 
hepatitis C (Dore et al., 1999; MacDonald & Wodak, 1999; HCCWA, 1998). The 
highly infectious, robust nature of the virus and the large pool of infection among 
injecting drug users, are factors that influence the high level of risk associated with 
injecting behaviour (Wodak & Crofts, 1996). Prevalence of hepatitis C is strongly 
associated with the duration of injecting, with the rates being as high as 40% after two 
years of injecting and approximately 90% to 100% for those who have injected for more 
than ten years (Crofts et al., 1993). Although there has been some recent evidence 
suggesting a decrease in the sharing of injecting equipment and therefore rate of 
transmission (Dore et al., 1999), some sub-groups of users are still at high risk of 
becoming infected with HCV, particularly in prisons where prevalence is very high 
(Dolan, 2000) and young people who are new to injecting (Williams, 2000). 
The principal strategy for preventing HCV transmission from injecting drug use, 
is to avoid re-using any injecting equipment (MacDonald & Wodak, 1999). Such 
initiatives include the provision of needle and syringe exchange programs, peer based 
education for injecting drug user groups on safer injecting practices, methadone 
maintenance programs and education and prevention activities in prisons (Williams, 
2000; Lowe & Cotton, 1999). However, despite these preventative efforts many people 
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still choose to share injecting equipment due to various factors such as lack of access, 
lack of knowledge or as part of an intimate, trusting relationship, consequently 
increasing the chances of transmitting or contracting hepatitis C (Williams, 2000). 
2.3 .2. Blood transfusions and blood products. 
Since the screening of blood supplies in 1990, transmission of hepatitis C 
through blood transfusions and blood products is extremely low, with approximately 
one case per 250,000 donations (Dore et al., 1999; HCCW A, 1998). Furthermore, due 
to the recent introduction of more sensitive nucleic acid testing for hepatitis C since 
June 2000, the risk of transmission from blood transfusions in Australia is virtually 
eliminated (DHAC, 2000). For people who received blood transfusions or blood 
products prior to 1990, a moderate risk of contracting hepatitis C exists {HCCW A, 
1998). This risk is the highest for haemophiliac patients or those who had multiple 
transfusions prior to the screening of blood supplies (Dore et al., 1999). 
2.3.3. Unsafe tattooing and body piercing. 
Tattooing and other skin penetration procedures such as body piercing have also 
been implicated as risk factors for the transmission of hepatitis C (Thompson, 
Hemberger, Wale & Crofts, 1996; HCCWA, 1998; MacDonald & Wodak, 1999). It has 
been suggested that such procedures pose a medium to high risk, particularly if not 
carried out under sterile conditions (HCCWA, 1998; Dore et al., 1 999). There is the 
potential for transmission to occur from client to client if tattooing needles and piercing 
equipment are not sterilised between clients, or if tattoo ink tubs are shared 
(Communicable Disease Control Branch (CBCD), 1999). Transmission can also occur 
from operator to client, or client to operator if the body artist does not use standard 
safety precautions for skin penetration procedures, such as wearing disposable gloves 
(CDCB, 1999). 
2.3.4. Needlestick injuries/ occupational transmission. 
Despite common belief, often due to media reports, the risk of transmitting the 
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hepatitis C virus through needle stick injuries is relatively low (Dore et al., 1 999). 
However, given the blood borne nature of transmission, healthcare workers are 
potentially at risk of exposure to hepatitis C (SCSI, 1 998). It is believed that the 
estimated risk of transmission following a needle stick injury involving HCV positive 
blood is about 4% (HCCW A, 1 998). To put this figure into perspective, the risk of 
hepatitis B and HIV transmission following exposure to positive blood, is 30% and 
0.4% respectively (HCCWA, 1 998). 
There has been limited research on occupationally acquired HCV infection in 
Australia, however one project by the National Centre in HIV Epidemiology and 
Clinical Research (NCHECR) monitors occupational exposure to HCV among 
healthcare workers in Australian hospitals (MacDonald, Correll & Dore, 2000). Since 
project monitoring began in 1995, no workers were reported as acquiring hepatitis C 
following exposure to the virus in the workplace. However, the authors noted that 
testing rates at three months after exposure were low and it is possible that there may 
have been workers who were infected and chose not to report this information 
(MacDonald, Correll & Dore, 2000). Despite the small amount of research conducted 
in this area, the risk of HCV transmission through occupational exposure or needlestick 
injuries appears to be low. Nevertheless, there is a risk and healthcare workers should 
be encouraged to adhere to standard safety precautions when conducting exposure 
prone procedures. 
2.3.5. Other modes of transmission. 
Hepatitis C transmission through routes other than those already discussed is 
generally thought to be uncommon, however any behaviour that involves blood-to­
blood contact is potentially a risk for the transmission of the virus (Dore et al., 1 999). 
Household transmission of hepatitis C appears to be extremely rare, although the 
possibility of blood to blood contact exists if toothbrushes, razors or similar items are 
shared, however there is no conclusive evidence to support this (MacDonald & Wodak, 
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1 999). 
It is generally recognised that hepatitis C is not a sexually transmitted virus and 
studies have concluded that sexual practices not involving blood, are considered to be 
very low risk (Dore, 2000b ). Contrary evidence suggests that approximately 1 0% of 
people with hepatitis C in the United States report acquiring the virus through sexual 
exposure (SCSI, 1 998). It is possible however, that for many people it is more 
favourable to report sexual transmission, rather than admit a history of injecting drug 
use. Despite inconclusive evidence about whether or not hepatitis C is transmitted 
sexually, general agreement is that: 
Sexual transmission is of very low prevalence. A very low 
proportion of new cases. There is argument about whether it is 
very, very low or just very low, but it certainly would not be more 
than one percent of all new transmissions (Wodak evidence, cited 
in SCSI, 1 998, p. 91 ). 
The risk associated with mother to child transmission (vertical transmission) is 
unclear, with figures estimating that less than 5% of babies will acquire the virus from a 
mother with hepatitis C (HCCWA, 1998). It is thought that high levels of virus in the 
mother at the time of pregnancy is the strongest risk factor for vertical transmission of 
hepatitis C (MacDonald & Wodak, 1999), however maternal co-infection with HIV has 
also been associated with an increased risk of transmission (Papaevangelou et al., 
1 998). 
2.4 Treatment 
Currently, there is no vaccine or effective cure for hepatitis C infection, however 
there are treatments and therapies available that seek to reduce viral replication and 
inflammation of the liver (Sievert & Korevaar, 1999). The goal of these treatments is to 
produce a sustained response (SR), which is defined by normal liver function tests and 
undetectable levels of the virus at either six or twelve months after the completion of 
treatment (Sievart & Korevaar, 1999). At present there are two types of anti-viral 
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treatments in Australia, interferon monotherapy and interferon combined with ribaviran 
( combination therapy) (Sievart, 2000). Studies suggest a significant advantage of 
combination therapy over interferon therapy alone, however both available treatments 
have limited success rates (between 19% and 64%) (Poynard et al., 1 998). More 
recently, it has been suggested that the use of newer, longer acting ('pegylated') 
interferons may further increase sustained response rates, although trials are still being 
conducted to determine their effectiveness (Sievart, 2000). 
Anti-viral treatment provides many people with a sense of hope that the virus 
may be eliminated, however it brings its own set of adverse physical and psychological 
side effects, which in turn can impact enormously on the life of the individual (Burrows 
& Bassett, 1 996; Sievart & Korevaar, 1 999). Reported side effects include nausea, flu 
like symptoms, weight loss, diarrhoea, anaemia, anxiety, depression and in some cases 
suicidal ideation (Sievart & Korevaar, 1 999). The debilitating effect of these symptoms 
can often cause people to cease treatment and thus lead to feelings of failure and 
hopelessness (Burrows & Bassett, 1996). In addition, it has been noted previously that 
treatment is only successful in a limited number of cases, so there are significant 
numbers of people who complete the course of treatment and either do not respond or 
relapse after a few months (Sievart & Korevaar, 1999). This again can lead to feelings 
of hopelessness, disappointment and anger in those who 'fail' treatment, as it is often 
viewed as the last chance or the last hope for eliminating the virus (Burrows & Bassett, 
1 996). 
2.5 He.patitis C and HIV: A Comparison 
The main characteristics of hepatitis C, including the prevalence, natural history, 
transmission and treatment have been discussed, thus providing a general overview of 
the nature of the virus. At this point it would be useful to summarise the features of 
hepatitis C by making a comparison with HIV, a virus of which the general community 
is relatively more aware (see Table 1 )  (NCHECR, 1999). 
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While some strong parallels can be drawn between the two viruses, there are 
also some striking differences (Orr & Leeder, 1998). For example, hepatitis C and HIV 
are both infectious blood-borne viruses, both went unrecognised for a period of time 
and both primarily affect populations who are socially marginalised (Orr & Leeder, 
1 998). However, hepatitis C was identified much later on the epidemic curve than HIV, 
and therefore a much larger pool of infection already existed within the population (Orr 
& Leeder, 1998). When compared to HIV, hepatitis C is a much more infectious and 
robust virus and therefore is more readily transmitted through the sharing of drug 
injecting equipment and needle stick injuries (Wodak & Crofts, 1996). Serious health 
complications occur more quickly in those with HIV in comparison to the slow acting 
nature of hepatitis C (Wodak & Crofts, 1996). 
Table 1 
Summary of HCV and HIV: A Comparison 
Feature HCV 
Start of epidemic early 1970's 
Prevalence 200, 000 
New infuctions / year 1 1 , 000 
Proportion of popu1ation 1 % 
infucted 
Mode of transmission 
Highest risk behavilur 
blood to blood contact 
irtjecting drug use 
HIV 
early 1980's 
18, 000 
500 
0. 1 % 
blood to blood contact 
sexual transmission 
male hm sexual contact 
It is clear that hepatitis C has become a widespread virus of epidemic 
proportions. Given the probability that a massive pool of unknown infection exists in 
the population, it seems certain that a significantly high number of people will be living 
with chronic liver disease, and the associated consequences, in the very near future (Orr 
& Leeder, 1 998). Attention needs to be given to the seriousness of this public health 
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issue, and in doing so the level of awareness and understanding of what hepatitis C 
means for the person needs to be increased. 
3. Impacts of Hepatitis C 
Given that hepatitis C is a chronic, long term illness, the importance of research 
examining the personal and social impacts of hepatitis C infection and subsequent 
quality of life, has only recently been acknowledged (AN CARD, 1999). As a result, the 
amount of research focusing on the consequences of hepatitis C infection and quality of 
life has increased, however it is relatively limited and the impacts are still not clearly 
understood. 
Quality oflife (QOL) is generally defined as an individual's overall satisfaction 
with life and sense of well-being (Koff, 1999). Although quality oflife is a concept that 
everyone intuitively understands, it is difficult to define and measure, due to the 
subjective nature of the term (Swain, 2000). Therefore, hepatitis C research has mainly 
focused on the more narrowly and specifically defined concept of health related quality 
oflife (HRQOL), which aims to estimate the impact of chronic illness on various 
domains, including physical functioning, somatic sensation, psychological status, social 
interactions and sense of well being (Koff, 1999). Research in this area has utilised 
both quantitative, and more recently qualitative methodologies, to identify the various 
personal and social impacts of hepatitis C and how these affect changes in HRQOL. 
The relevant literature will be discussed in more detail. 
3.1 . Quantitative Assessment of Health Related Quality of Life (HROOL) 
To date, the measurement ofHRQOL among people with hepatitis C, has most 
frequently been undertaken through the use of multi-item questionnaires and self report 
survey instruments (Swain, 2000). Typically these measures are designed to assess an 
individual's perception of illness and quantify the impact on their life (Swain, 2000). 
The main instruments used to measure HRQOL among hepatitis C populations, are 
generic questionnaires such as the Short-Form 36 (SF-36) (Ware & Sherbourne, 1992) 
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and hepatitis C specific assessment tools such as the Hepatitis Quality of Life 
Questionnaire (HQLQ) (Bayliss, Gandek, Bungay, Sugano, Hsu & Ware, 1 998) and the 
Chronic Liver Disease Questionnaire (CLDQ) (Younossi, Guyatt, Kiwi, Boparai & 
King, 1999). 
3.1 . 1 .  Short-form 36 (SF-36). 
Perhaps the most common measurement tool to be used in hepatitis C research, 
is the Short-Form 36 (SF-36), a generic questionnaire designed to assess health related 
quality of life (Ware & Sherboume, 1 992). The SF-36 is a multi-item scale which 
measures eight health related concepts, namely physical function; social functioning; 
role limitations due to physical problems; bodily pain; mental health; role limitations 
due to emotional problems; vitality and general health perceptions (Ware & Sherboume, 
1992). The SF-36 is self-administered, is rapid and easy to complete and has shown to 
have acceptable reliability and validity among various populations (Koff, 1 999). 
Studies utilising the SF-36 among people with chronic hepatitis C, are only 
relatively recent and generally they have demonstrated a significant decline in all eight 
sub-scales of the SF-36 for those infected with the virus, when compared to healthy 
controls (Bonkovsky & Woolley, 1 999; Carithers, Sugano & Bayliss, 1 996; Foster, 
Goldin & Thomas, 1 998). Although the results from these studies indicated that people 
living with HCV had lower quality oflife across all domains, the greatest reductions 
appeared to be on the physical sub-scales as opposed to the categories measuring mental 
and emotional health, suggesting that the greatest impact of HCV was of a physical 
nature (Foster et al., 1 998; Bonkovsky & Woolley, 1 999). 
Foster et al. (1 998) also compared quality of life in people with chronic HCV, 
with those who were infected with chronic hepatitis B. Interestingly, HCV participants 
scored lower on all domains of the SF-36, however scores were only significantly 
poorer in areas of social functioning, physical role limitations and vitality ( energy and 
fatigue) (Foster et al., 1 998). These results suggest that the reduction in quality of life 
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among HCV participants could not be attributed to the degree of liver inflammation, 
and therefore the nature of impairment associated with HCV may be qualitatively 
different to the symptoms associated with HBV (Foster et al., 1998). 
Bonkovsky and Woolley ( 1999) also evaluated the effect of chronic hepatitis C 
on HRQOL by using the SF-36. The main aim of this study was to determine whether 
treatment of 642 participants with interferon therapy, subsequently improves HRQOL. 
Similar results to Foster et al. (1998) were reported, with baseline measures ofHRQOL 
being significantly lower across all domains of the SF-36 for HCV patients, when 
compared to healthy controls (Bonkovsky & Woolley, -1999). In addition, when 
compared to non-responders, it was found that those who had a sustained response to 
treatment, showed a significant improvement in HRQOL within five of the eight sub­
scales, six months after treatment had ceased (Bonkovsky & Woolley, 1999). One 
significant flaw in this study was that participants were not blind to their responses 
during the treatment phase. In other words, participants knew whether or not they were 
responding to interferon and this awareness may have influenced their perceived health 
status (Swain, 2000). 
There are also some general limitations of studies that have used the SF-36 to 
measure HRQOL among people with hepatitis C and therefore results should be 
interpreted with caution. Most studies compared HCV participants with 'healthy' rather 
than 'normal' control populations, therefore the differences in perceived quality of life 
may appear to be more pronounced than what is actually the case (Swain, 2000). 
Another big problem with the SF-36 is the fact that it is a generic assessment tool, 
which is useful for direct comparisons ofHRQOL between people with hepatitis C and 
other populations, however they are based on the assumption that chronic illnesses 
impact on people in similar ways (Swain, 2000; Garrett & Conrad, 2001 ). In addition, 
the use of generic questionnaires gives rise to the possibility that information regarding 
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disease-specific impacts and changes in functioning can be lost (Borgaonkar & Irvine, 
2000). 
3.1.2. Hepatitis C specific measures of HROOL 
The use of generic instruments to measure HRQOL and the awareness of their 
associated limitations, has led to the recent development of assessment tools that are 
specific to hepatitis C. One such attempt has been by Bayliss et al. (1998) who 
developed the Hepatitis Quality of Life Questionnaire (HQLQ), a 69-item questionnaire 
designed to measure both generic functioning and disease-specific health outcomes. 
The HQLQ included all eight scales from the SF-36, in addition to measures of nine 
other generic and hepatitis C specific health concepts. Bayliss et al. tested the 
questionnaire on people with chronic hepatitis C who were receiving interferon 
treatment and found that participants scored lower on the generic scales than patients 
with other chronic illnesses, and worse than a healthy general population. Although the 
disease-specific scale scores were also found to be lower for hepatitis C, the HQLQ 
appeared to have no significant advantage over using the SF-36 alone (Bayliss et al., 
1998). Furthermore, so far the HQLQ has only been used with participants who are 
receiving interferon treatment and the effectiveness of this questionnaire on untreated 
hepatitis C populations, is yet to be determined. 
Another disease specific instrument called the Chronic Liver Disease 
Questionnaire (CLDQ) has also been recently developed and is designed to measure 
HRQOL in people with chronic liver disease, including hepatitis C (Y ounossi et al., 
1999). Literature, expert opinion and patient focus groups, were used to generate the 29 
item questionnaire, which focuses on six domains that impact on quality of life for 
people with chronic liver disease: fatigue, activity, emotional function, abdominal 
symptoms, systemic symptoms and worry (Younossi et al., 1999). The CLDQ has been 
shown to have a number of advantages including short and easy administration, 
moderate test-retest reliability after six months and appears to discriminate between 
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people with varying degrees of liver damage (Younossi et al., 1 999). The CLDQ is still 
in the initial stages of being utilised to assess HRQOL in people with hepatitis C and 
more research is needed to evaluate it's efficacy, however the CLDQ exhibits a number 
of potential strengths which may allow future widespread application among this 
population. 
3 . 1 .3 .  General limitations. 
Both generic and disease specific measures of HRQOL are in the beginning 
stages of development, particularly with respect to hepatitis C. Nevertheless, results 
from studies conducted so far, have suggested that people living with hepatitis C 
experience a significant decline in quality oflife, with the greatest deficits appearing to 
be physical in nature. It has been argued however, that using questionnaire type tools to 
assess HRQOL does not directly address the mechanisms underlying the apparent 
decline (Koff, 1999). In other words, this method of assessment demonstrates that there 
are impacts of hepatitis C that have a detrimental affect on quality oflife, but they do 
not specifically explain what these impacts are or why they affect quality of life (Koff, 
1 999). Despite this limitation, HRQOL assessment tools have a very important place in 
hepatitis C related research and can be used to evaluate treatment efficacy and enhance 
knowledge of the virus (Borgaonkar & Irvine, 2000). 
3.2. Qualitative Research: Personal and Social Impacts 
Recent interest in identifying and understanding the potential impacts of 
hepatitis C, has led many researchers to adopt a qualitative approach to explore these 
impacts in more detail (Garrett & Conrad, 200 1 ;  Burrows & Bassett, 1 996). It is argued 
that qualitative inquiry is better suited to develop an understanding of personal 
meaning, while revealing important insights into human experiences (Miles & 
Huberman, 1994). Research in this area has attempted to explore the impacts of 
hepatitis C by conducting in-depth interviews or focus groups, in order to understand 
the personal experiences of people living with the virus (Crossen, Brunton, Plumridge 
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& Jang, 1999; Burrows & Bassett, 1996; Garrett & Conrad, 2001). Unfortunately, the 
amount of formal research in this area is relatively scarce and much of the current 
knowledge regarding the personal and social impacts of hepatitis C, has come from 
personal submissions (SCSI, 1 998) or anecdotal evidence provided from case notes or 
workers in the field (Lowe & Cotton, 1 999). However, the research suggests that a 
positive diagnosis of hepatitis C results in a range of physical, psychological and social 
impacts, which will be discussed further. 
3.2. 1 .  Receiving the diagnosis 
For many people, receiving the news that they have contracted hepatitis C, is a 
shocking and traumatic experience (Burrows & Bassett, 1996). In most cases, it 
appears that people are generally informed by their doctor, however some people have 
reported being told over the phone or via letters from blood banks (Crossen et al., 1 999; 
Burrows & Bassett, 1996). While a small minority of participants in Burrows and 
Basset's study were satisfied with the amount of information and support they received 
at the time of diagnosis, there have been a large number people who were unhappy with 
the way they were informed (Crossen, et al. 1 999; Burrows & Bassett, 1 996). Pre-test 
and post test counselling is designed to reduce the impact of a positive diagnosis by 
providing sufficient information about possible outcomes, educating the person on the 
risk of transmission and ensuring that there is adequate support available (McCoy, 
Watson & Kosky, 1999). Unfortunately, studies have indicated that the number of 
people who actually receive this counselling are limited (Crossen et al., 1 999; Burrows 
& Bassett, 1 996), and many people experienced increased stress and anxiety due to the 
lack of information and uncertainty surrounding the outcomes of hepatitis C infection 
(Garrett & Conrad, 2001 ;  Crossen et al., 1999; Lowe & Cotton, 1 999). 
3.2.2. Physical symptoms. 
By far the most commonly reported physical symptom of chronic hepatitis C has 
been fatigue, ranging from minimal or episodic lethargy, to overwhelming and 
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debilitating exhaustion (Burrows & Bassett, 1 996; Garrett & Conrad, 2001 ). One of the 
reported difficulties associated with fatigue is the unpredictability of onset, which for 
many people means they can not plan for more than a day at a time (Glacken, Kernohan 
& Coates, 2001 ). The experience of fatigue for many people with hepatitis C has also 
been reported to contribute to a reduction in social mobility and thus can influence a 
sense ofisolation (Glacken et al., 2001 ). 
Other common physical symptoms include nausea, headaches and pain in the 
right side of the abdomen, however muscle aches, intolerance to fatty foods, skin rashes 
and weight loss have also been reported (SCSI, 1 998; Burrows & Bassett, 1 996). It has 
been noted previously that people on interferon or combination treatment, may also 
experience adverse physical symptoms (see section 2.4). It is important to note that 
participants in these studies generally did not experience symptoms all of the time and 
they could be more or less severe on different days (Burrows & Bassett, 1 996). 
Garrett and Conrad (2001 )  found that the physical impacts of hepatitis C were 
often surrounded by feelings of uncertainty, in particular the unpredictability associated 
with the onset of symptoms and what that meant in regards to the progression of the 
virus. White and Lubkin ( 1998) suggest that the uncertainty and unpredictable nature 
associated with many chronic illnesses can have enormous implications for the 
individual, often resulting in a number of psychological effects, which will be discussed 
further in the next section. 
3.2.3. Psychological and emotional impacts. 
Studies suggest that a positive diagnosis of hepatitis C may also create 
significant psychological and emotional impacts (SCSI, 1 998). As noted in the previous 
section, it appears that in many cases the presence of physical symptoms can often lead 
to psychological effects such as depression, mood swings, anxiety, stress and decreased 
self esteem (Loveday et al., 1 999). Depression seems to be the most commonly cited 
psychological effect (Burrows & Bassett, 1 996), and appears to be more significant in 
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those who have been diagnosed for more than five years, or for those who are over fifty 
years of age (Kraus, Schafer, Csef, Scheurlen & Faller, 2000). This suggests that the 
amount of time that a person knows they have hepatitis C, could possibly influence their 
emotional state (Kraus et al, 2000). 
Other psychological impacts of hepatitis C such as short term memory loss 
(Garrett & Conrad, 2001 ), irritability and 'shattered dreams' have also been reported 
(Burrows and Bassett, 1 996). An interesting exploratory study by Glacken et al.(2001 ), 
found that the majority of participants experienced an altered self concept and decreased 
self esteem, following a positive diagnosis. Many participants considered themselves as 
'contaminated', 'dirty' and 'unclean', mixed in with feelings of anger, bitterness, fear, 
frustration and a sense of hopelessness (Glacken et al., 2001 ). It has also been reported 
that the ambiguous nature ofHCV can lead to a reduced sense of control and 
uncertainty about the future (Garrett & Conrad, 2001 ). 
3.2.4. Coping and support 
A cross sectional study by Kraus et al. (2000), explored coping styles among 
people with chronic hepatitis C. These authors found that the most common coping 
mechanism was problem solving behaviour, however distraction and self re-evaluation 
were also frequently employed (Kraus et al., 2000). Other reported methods of coping 
with physical symptoms such as fatigue, have been diet and exercise (Garrett & Conrad, 
200 1 ), and stress management techniques such as meditation, yoga and counselling 
(Stadden, Hickey, Dunn & Beard, 1998). 
Social support has shown to be an important factor in reducing the negative 
impacts of a positive diagnosis (Glacken et al., 2001 ). Many participants in New 
Zealand based research reported that friends and family provided the greatest amount of 
support, while others mentioned their general practitioner and hepatitis C support 
groups (Crossen et al., 1999). 
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3.2.5. Effect on family and relationships. 
Reports of personal experiences have suggested that hepatitis C can have a 
negative impact on family and relationships (Burrows & Bassett, 1996; SCSI, 1998). 
Fear of transmission to partners and children appears to be a common example, even 
though the risk is very low (Loveday et al ., 1999). This can lead to a reduction in the 
amount of interaction with partners and children. Examples given by women have 
included being cut off from their families because of hepatitis C due to fear and 
confusion concerning the risks of transmission (Gifford & O'Brien, 2001 ). Some 
examples of comments given by women include: 
I used to be able to hug them (my family) and kiss them and now I'm 
not allowed to touch them or anything (Gifford & O'Brien, p l2.) 
I planned to have children in the next few years and that's really scary 
because it's not something I want to pass on to my kids. Do I have a 
right to marry this man and have his children if I'm going to put my 
kids at risk? (Gifford & O 'Brien, p l2.) 
Other impacts on family are influenced by the ability to have the physical 
energy to look after, raise and interact with children, which for many people is greatly 
reduced (SCSI, 1998). Some people have reported negative attitudes, behaviour or 
rejection from partners and friends, mainly due to fear and ignorance, while others have 
reported positive support and the strengthening of relationships (Burrows and Bassett, 
1996). 
3.2.6. Effects on work. 
Many people with hepatitis C have found that the virus can have a devastating 
effect on the ability to continue their jobs and careers, due to increasing fatigue or stress 
(Burrows & Bassett, 1996). In a study exploring the experiences of women, it was 
found that the difficulty in gaining and maintaining employment led to negative 
financial implications and economic hardship (Gifford & O'Brien, 2001). Other 
reported impacts have included having to leave current jobs, engaging in a total career 
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change or being sacked because of a reduced ability to keep up (Burrows & Bassett, 
1996). Another serious impact of being diagnosed with hepatitis C, is the experience of 
discrimination, stigma and isolation in the work place (Lowe & Cotton, 1999), and 
exploration of this issue will be discussed further in section 3.2.8. 
3.2.7. Disclosure. 
While there is no legal obligation to disclose hepatitis C status, it appears to 
remain a big issue and can have significant impacts for many people (HCCWA, 1998). 
Disclosure was a major issue for the women in Gifford and O'Brien's (2001) recent 
study. The dilemma facing these women, and indeed many people with hepatitis C, is 
the choice between telling someone their status in order to gain support or warn them of 
potential risk, and the real fear of being rejected or being subjected to stigma and 
discrimination (Gifford & O'Brien, 2001; Burrows & Bassett, 1996). Many people 
have experienced adverse consequences within family, friends, relationships and work 
and personal anecdotes include: 
I need some information to send to my brother who won't let me 
touch his kids. Telling my family was the biggest mistake I ever 
made (Burrows & Bassett, p.25). 
I've lost a lot of people - ifl make coffee at my house people won't 
drink it and I haven't seen some of them since telling them (Burrows 
& Bassett, p.26). 
Other people have reported that although disclosure can be difficult, it can be a 
positive experience: 
I'm fortunate because a friend of mine is also positive. She's very 
supportive and helpful.. .telling people is part of the process of 
accepting it (Burrows & Bassett, p.25). 
Whether the experience of disclosure is positive or negative, the decision to do 
so often creates a lot of stress and anxiety and the impact can be quite significant 
(Burrows & Bassett, 1996). For example, for some people, the fear of potential 
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rejection is so great that they choose not to involve themselves in relationships (Garrett 
& Conrad, 2001). 
3.2.8. Discrimination and stigma 
There is a growing amount of literature that powerfully reveals the extent to 
which people living with HCV experience stigmatisation and discrimination. Stigma is 
a socially constructed concept associated with shame and discredit, whereas 
discrimination is the differing treatment or action which is based on stigma (Ward, 
Colebome & Fort, 2000). It is suggested that characteristics which contribute to the 
stigmatisation of many chronic diseases include an unclear cause or progression, 
ineffective treatment, transmissible nature and association with an already marginalised 
group (Saylor & Yoder, 1998). All of these factors are characteristic of hepatitis C and 
therefore various degrees ofHCV related stigma and discrimination are present in the 
community, largely as a result of negative attitudes towards injecting drug users (Ward 
et al., 2000; SCSI, 1998; Burrows & Bassett, 1996). 
Research by Crofts, Louie and Loff ( 1997) reported that the range of settings in 
which hepatitis C discrimination occurred was extensive. The majority of 
discrimination incidents were reported to have occurred in health care settings (56%), 
while others had occurred in domestic settings (22%), occupational settings (20%) and 
recreational settings (5%). A wide range of discriminatory incidents were also reported 
by participants in Burrows and Bassett's (1996) study. A large number of people noted 
that the negative attitudes they experienced, were influenced by the assumption that 
people with hepatitis C are injecting drug users, and a high level of discrimination was 
reported as coming from health care workers (Burrows & Bassett, 1996). 
When someone gets cancer from smoking, they're treated respectfully 
in hospital. Whereas with hepatitis C it's 'You knew it (injecting 
drug use) could be dangerous. You deserve what you get'. They 
want to get you out as quickly as possible. (Burrows & Bassett, p.33). 
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Dealing with stigma and discrimination is often an everyday reality for people 
living with hepatitis C and can have a significant impact not only on the life of the 
individual, but also on the lives of their family and friends (Ward, Colebome & Fort, 
2000). Reported impacts of stigma have included devalued sense of self, diminished 
self esteem (Gifford & O'Brien, 2001), secondary health care, ending of relationships 
and termination of employment (Crofts, Louie & Loff, 1997). 
These experiences appear to be a common link between many studies exploring 
the impacts of hepatitis C and some have suggested that it has become a secondary and 
underlying epidemic that people living with the virus have to deal with (SCSI, 1 998). 
The recent acknowledgement of the widespread extent of hepatitis C related 
discrimination, has led to the National Hepatitis C Strategy stating the reduction of 
discrimination, particularly in healthcare settings, as a national priority (DHAC, 2000). 
It is clear that more research is needed to further understand the extent and nature of 
hepatitis C related stigma and discrimination, in order to reduce the impact of this 
significant issue. 
3 .3. Development of a Socio-Cultural Perspective 
Although research exploring the impacts of hepatitis C is relatively new, 
qualitative studies have begun to provide a clearer picture of how these impacts affect 
quality oflife. However some researchers have argued that hepatitis C is primarily 
viewed as a medical condition, with emphasis on the impact of physical symptoms 
(Hepworth & Krug, 1999). It has also been suggested that the non-physical effects of 
hepatitis C are typically represented as being located within the individual and as 
individual problems (Hepworth & Krug, 1999). A recent change in thinking has led 
some researchers to view hepatitis C as not only a medical, physical or individual 
problem, but as a virus whose impacts are influenced by social, cultural and political 
factors (Glacken et al., 2000; Hepworth & Krug, 1999). These researchers argue that a 
positive hepatitis C diagnosis accompanies a range of impacts to which they have to 
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adapt, and these changes are not only derived from psychological reactions, but also 
from the social and cultural relationships in which the individual is embedded 
(Hepworth & Krug, 1999). 
This viewpoint is consistent with Bronfenbrenner's (1 979) systems theory, 
which argues that an individual exists in, and is influenced by a series of interconnected 
systems, within their environment. Bronfenbrenner's theory has long been associated 
with human development, however a similar framework could be applied to the 
experience of chronic illnesses (Strauss et al., 1 984). For example, some aspects of 
hepatitis C such as symptoms of fatigue and depression (Burrows & Bassett, 1 996; 
SCSI, 1 998), affect the person at an individual level which Bronfenbrenner describes as 
the microsystem. Impacts at a social level, including negative impacts on work, family 
and relationships (Burrows & Bassett, 1 996; SCSI, 1 998) and inadequate pre-test and 
post-test counselling (Crossen et al., 1 999) could be described as the mesosystem 
(Bronfenbrenner, 1 979). Negative community attitudes and social policy are aspects of 
an even broader environmental context, which Bronfenbrenner calls the exosystem. 
A systems or socio-cultural approach also suggests that impacts at one particular 
level of the system will have implications for other levels of the system 
(Bronfenbrenner, 1 979). For example, in relation to hepatitis C, the fear of 
discrimination may have an effect on the working environment. While some current 
research has hinted at the potential applicability of an ecological approach to 
understanding the personal and social impacts of hepatitis C, no such study has 
attempted to apply a systems framework to understand these impacts. 
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4. Overview and Future Directions 
It is clear that hepatitis C has become a widespread virus of epidemic 
proportions within the Australian community. Given the current prevalence and 
incidence rates, it is probable that a significantly high number of people will be living 
with chronic liver disease, and the associated consequences, in the very near future (Orr 
& Leeder, 1 998). There is currently no vaccine, or cure, and treatment is not successful 
in many cases, so HCV is for most people a life long condition with long term effects. 
As a result, attention.needs to be given to the seriousness of this public health issue, and 
the level of awareness and understanding surrounding the impacts of hepatitis C needs 
to be increased. 
In comparison to the amount of research on the epidemiology, prevention and 
treatment of hepatitis C, relatively few studies have documented the extent to which a 
positive diagnosis impacts on various aspects of a person's life (Garrett & Conrad, 
200 1 ;  Burrows & Bassett, 1 996; Crofts, Louie & Loff, 1997). Quantitative studies have 
utilised both generic and hepatitis specific assessment tools to measure the concept of 
health related quality of life. Generally results have indicated that HCV can lead to a 
significant decline across all areas, particularly within the physical domain. However, 
quantitative quality of life research is limited in the amount of detail that can be 
provided about the nature of the impacts and how the person is affected. The further 
development of hepatitis specific assessment tools and the increased use among people 
with HCV, is needed to improve the efficacy of these instruments. 
In reviewing the qualitative literature, a more detailed picture of personal 
experiences has emerged. There appears to be a wide range of impacts for people living 
with hepatitis C, ranging from physical symptoms such as fatigue, to the experience of 
stigma and discrimination. The findings from these studies not only indicate significant 
personal impacts for the individual, but social impacts as well, however more research 
needs to be conducted. In order to provide adequate care and support for people living 
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with hepatitis C, it has been recommended that further knowledge is needed in order to 
understand the impacts of a hepatitis C diagnosis, and how they affect quality of life 
(DHAC, 2000). Research is needed to explore how hepatitis C impacts on the physical, 
psychological, social and cultural environments of an individual, and how these 
different spheres can impact on the experience of hepatitis C. 
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Abstract 
Hepatitis C (HCV) has become one of the most widespread blood borne viruses 
in many Westernised countries and a positive diagnosis can significantly impact on 
various aspects of a person's life. Using a systems perspective, the present study aimed 
to explore the physical, psychological and social impacts ofHCV on 12 participants 
who were living with the virus in Perth, Western Australia. Qualitative semi-structured 
interviews were conducted, and content analysis revealed six main themes: .finding out; 
being infectious; disclosure; stigma; symptoms; dealing with it. A comprehensive 
systems framework is used to understand and explain the impacts ofHCV and how 
these affected participants' quality of life. The findings have implications for providers 
of health care, helping services, the general community and makers of government 
policy. 
Keywords: Hepatitis C, qualitative research, impacts, systems framework, 
discrimination 
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The physical, psychological and social impacts of hepatitis C and the effect on quality 
of life 
In the past decade, hepatitis C (HCV) has become one of the most widespread 
blood-borne viruses, creating a major public health issue in Australia (Department of 
Health and Aged Care (DHAC), 2000). It is estimated that over 200,000 people have 
been infected with hepatitis C and up to 1 1 ,000 new infections are reported each year 
(DHAC, 2000). Hepatitis C affects the liver and is transmitted via blood to blood 
contact, with the large majority of infections resulting from the sharing of injecting drug 
equipment (Hepatitis C Council of WA (HCCWA), 1 998). Other modes of 
transmission include unsafe tattooing, body piercing or receiving blood transfusions 
prior to the screening of supplies in 1990 (HCCWA, 1 998). Approximately 80-85% of 
people who contract the hepatitis C virus become chronically infected and may 
experience various ranges of liver damage, possibly leading to cirrhosis, liver cancer or 
liver failure (Dore, 2000; Lin, Barker & Batey, 1 999). As there is no vaccine available 
for hepatitis C and treatment is not successful in a significant number of cases (Standing 
Committee on Social Issues (SCSI), 1 998; Sievert & Korevaar, 1 999), for many people 
hepatitis C is a life long condition with long-term effects (Lowe & Cotton, 1 999; SCSI, 
1 998; Loveday, Deakin & Neophyton, 1 999). 
There has been a large amount of research on the epidemiology (Dolan, 2000; 
Dore, 2000), prevention (Wodak & Crofts, 1 996) and treatment (Sievert & Korevaar, 
1 999) of hepatitis C, however the importance of examining the personal and social 
impacts ofHCV infection and subsequent effects on quality of life, has only recently 
been acknowledged (ANCARD, 1999, Garrett & Conrad, 200 1 ;  Burrows & Bassett, 
1 996; Crofts, Louie & Loff, 1997). Quantitative research has utilised both generic and 
disease specific questionnaires to measure health related quality of life (HRQOL) 
among people living with hepatitis C. Generally it has been suggested that the hepatitis 
C virus is associated with a significant decline in quality of life, with the greatest 
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deficits appearing to be physical in nature (Bonkovsky & Woolley, 1 999; Bayliss et al, 
1998; Foster, Goldin & Thomas, 1998). 
While it is widely acknowledged that physical symptoms undeniably affect 
quality of life, a number of qualitative studies have suggested that other issues such as 
disclosure, family and relationship impacts also appear to be serious concerns for 
people living with hepatitis C (Burrows & Bassett, 1 996; Garrett & Conrad, 200 1 ;  
Crofts, Louie & Loff, 1997). In addition, there has been a growing body of literature 
which indicates that discrimination and stigmatisation are frequently experienced by 
people with the virus, largely as a result of negative attitudes towards injecting drug 
users (Ward, Colebome & Fort, 2000; SCSI, 1998; Burrows & Bassett, 1996). Crofts, 
Louie and Loff (1 997) interviewed a number of people with HCV about their 
experiences of discrimination and found that the range of settings in which hepatitis C 
discrimination occurred was extensive, with a large proportion of incidents taking place 
in health care settings. 
Hepatitis C has been commonly viewed in the literature as a medical or physical 
problem which primarily impacts on the individual. However, a recent change in 
thinking has led some researchers to view the experiences of hepatitis C in a wider 
context, with impacts being influenced by social, cultural and political factors (Glacken, 
Kemohan & Coates, 2001 ;  Hepworth & Krug, 1999). These researchers argue that a 
positive hepatitis C diagnosis accompanies a range of impacts to which people have to 
adapt, and these changes are not only derived from the psychological reactions of 
having a chronic illness, but also from the social and cultural relationships in which the 
individual is embedded (Hepworth & Krug, 1999). 
This viewpoint is consistent with Bronfenbrenner's (1 979) systems theory, 
which argues that an individual exists in, and is influenced by a series of 
interconnecting systems, within their environment. Bronfenbrenner's theory has long 
been associated with human development, however a similar framework could be 
L 
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applied to the experience of chronic illnesses (Strauss et al., 1 984). For example, some 
aspects of hepatitis C such as symptoms of fatigue and depression (Burrows & Bassett, 
1 996; SCSI, 1 998), affect the person at an individual level, which Bronfenbrenner 
describes as the microsystem. Impacts at a social level, including negative impacts on 
work, family and relationships (Burrows & Bassett, 1 996; SCSI, 1 998) and inadequate 
pre-test and post-test counselling (Crossen et al., 1 999) could be described as the 
mesosystem (Bronfenbrenner, 1979). Negative community attitudes and social policy 
are aspects of an even broader environmental context that Bronfenbrenner calls the 
exosystem. 
A systems or socio-cultural approach also suggests that changes at an individual, 
social or cultural level, will ultimately have implications for other levels of the system 
(Bronfenbrenner, 1 979). For example, in relation to hepatitis C, physical impacts such 
as fatigue (individual) may have an effect on the working environment (social). While 
some current research has hinted at the potential applicability of an ecological approach 
to understanding the personal and social impacts of hepatitis C, no study has attempted 
to apply a systems framework to understand these impacts. 
Furthermore, in order to provide adequate care and support for people living 
with HCV, it has been recommended that further knowledge is needed to understand the 
impacts of a positive diagnosis (DHAC, 2000). Using a systems perspective, this study 
sought to examine the experiences of people living with HCV and explores the physical, 
psychological and social impacts of the virus. In addition, the present study aimed to 
develop a framework in which the impacts ofHCV could be clearly understood, and 
how these aspects affect quality of life for people living with the virus. 
Method 
Design 
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A qualitative approach, using semi-structured interviews, was adopted for the 
present study in order to understand the experiences of people who were living with 
hepatitis C. It is argued that qualitative inquiry is better suited to develop an 
understanding of meaning while allowing a free and open forum to expose regularities 
and reveal insights to human experiences (Miles & Huberman, 1994). While 
quantitative research focusing on hepatitis C has indicated that people living with the 
virus experience a reduction in quality of life, it does not explain what the specific 
impacts are or how they affect quality of life (Koff, 1999). Qualitative research is 
valuable as it allows an in depth exploration of the personal and social impacts of 
hepatitis C and can reveal details that quantitative inquiry may miss. 
Participants 
The aim of this study was to explore people's experiences of hepatitis C, 
therefore it was essential that participants had the required knowledge and 
understanding of these experiences. It was decided that purposeful, maximum variety 
sampling would be used to select participants who were positively diagnosed and living 
with hepatitis C. Purposeful selection allows the sample to be information rich (Patton, 
1990), while selecting participants from a large variety of backgrounds will increase the 
transferability of the findings (Nagy & Viney, 1994). The participants were recruited 
through the Hepatitis C Council of Western Australia, the Haemophilia Foundation of 
Western Australia, and from the general community. 
Twelve participants took part in this study, 6 males and 6 females. All 
participants lived in the capital city of Perth metropolitan area, and had been positively 
diagnosed with the hepatitis C virus. Participant's ages ranged from 23 to 61 years, and 
despite the fact that no age limits were placed on the sample, 10 out of 12  were middle 
aged (37-5 1 years). Four participants were single, six were either married, had partners 
1 
l 
I 
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or were in a defacto relationship, and two of the participants were widowed. Seven 
participants believed they contracted hepatitis C through injecting drug use, four 
believed they contracted the virus through blood transfusions or blood products and one 
participant did not say. 
Materials 
The materials for this study included a semi-structured interview schedule 
(Appendix A) and an audio tape recorder. The semi-structured interview schedule was 
chosen as a number of advantages using this method of interviewing have been 
reported. For example, the semi-structured format facilitates empathy and rapport with 
the participants, allows for greater flexibility during the interview process and tends to 
produce richer data {Smith, 1995). 
The interview schedule included 13 open ended questions that were designed to 
elicit discussion about the impacts of hepatitis C at a personal, social and cultural level. 
The development of these questions was guided by concepts from the literature and 
were also examined by a professional who had extensive experience and knowledge in 
the area of hepatitis C, in order to assess whether the questions were appropriate and 
adequate. Questions focusing on personal impacts included 'What symptoms, if any, 
have you experienced as a result of hepatitis C?' and 'How do you cope with these 
symptoms?' Examples of questions that related to social impacts, focused on sources of 
support and interpersonal relationships, such as 'What or who are your sources of 
support?' and 'How do you think hepatitis C has impacted on you socially?' Questions 
designed to explore impacts at a cultural level focused on the time of diagnosis and 
aspects of discrimination, for example 'Tell me about your experience of learning that 
you have hepatitis C'. 
Procedure 
With permission of the Hepatitis C Council of WA, advertised invitations 
{Appendix D) to participate in the study were placed in newsletters and were distributed 
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at support groups and public meetings. Advertisements were also placed at the 
Haemophilia Foundation of WA and in two local community newspapers. People who 
wished to participate were able to call the researcher on the given phone number. Once 
contact was made with the participant, a convenient time was set up to conduct the 
interviews. Most interviews were conducted at the Hepatitis C Council of WA, 
however this was not possible for some participants and in those cases the interviews 
were conducted in the participant's home. 
Prior to the commencement of each interview, the participant was given an 
information letter (Appendix B), which outlined the nature of the study, what they were 
required to do, confidentiality, voluntary participation and the freedom to withdraw at 
any time. After the opportunity to ask questions or discuss any concerns, informed 
consent was obtained (Appendix C) and the interview was conducted and tape recorded. 
The interviews took between 25 and 60 minutes to complete and were conversational in 
nature. Given the possibility of participants experiencing negative emotions or distress 
as a result of sharing personal experiences, referrals to the Hepatitis C Council 
Information and Support Line and 24 hour support lines such as Crisis Care, were made 
available to all participants. At the completion of the interviews, the audio tapes were 
transcribed, coded and analysed by the researcher. 
Data Analysis 
The data was analysed using a method that focused on analysing qualitative data 
from semi-structured interviews (Smith, 1 995). This process involved carrying out a 
number of steps for each transcript, in order to understand the content and complexity 
of meanings and experiences from the participants' point of view. Each transcript was 
read through a number of times and key words, concepts, interesting points and 
summaries were recorded to provide a general feel of each participant's experience of 
living with HCV. Using these notes, a list of themes was then generated for each 
transcript. A question ordered matrix was also used to display key responses to each 
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question, with rows representing each participant and columns representing the 
interview questions (Miles & Huberman, 1994). Through using these methods, 
similarities and connections between participants were identified, and recurring issues 
were organised into a list of master themes and sub-themes that represented the 
experiences of participants. The original data was then re-examined and coded for 
actual instances of the main themes. 
Credibility is described as the extent to which the findings represent the actual 
values, feelings and beliefs of the participant and is similar to the concept of internal 
validity (Nagy & Viney, 1994). In order to maintain credibility, emerging themes were 
checked against the raw data throughout the analysis process and interpretations were 
checked with a number of participants. Reliability was maintained by establishing an 
audit trail, which documented details of how the data was analysed, including methods 
of data reduction and verification of conclusions (Morse, 1994 ). 
Findings 
The above method of analysis revealed six main themes, which best illustrated 
the experiences of living with hepatitis C and the various impacts associated with the 
virus. The main themes were Finding Out, Being ' Infectious', Disclosure, Stigma, 
Symptoms and Dealing With It. Each of these themes included a number of sub-themes 
and will be discussed below. 
Finding Out 
The first main theme related to participants' experiences of 'Finding Out' about 
their positive HCV diagnosis, and was important because this was the time when the 
first impacts of the virus were felt for many people. When asked to tell their story about 
how they found out, participants described the way they were told, the information they 
were told and how they reacted {Table 1 ). 
Most participants were informed that they were HCV positive from doctors or 
via blood banks, after they had donated blood. One participant was informed through 
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the mail. None of the participants knew much about hepatitis C at the time of their 
diagnosis and for most it was totally unexpected, suggesting that no pre-test counselling 
had occurred. It also seemed evident that in most cases, adequate post-test counselling 
was not performed. Participants explained that they either received no information 
about HCV whatsoever, very limited information such as 'don't drink alcohol or eat 
fatty food', or wrong information such as 'don't have sex', 'don't touch food with out 
gloves' or 'if you don't have treatment you will get cancer and die'. This led to 
unnecessary stress and anxiety, as people had no idea what HCV was or what it was 
going to do to them. Only one participant out of twelve felt they received adequate 
information at the time of diagnosis. 
Participants' reactions to a positive diagnosis were divided into three types. 
There were those who viewed a HCV diagnosis as being 'no big deal' or did not see it 
as being an important part of their life at the time. This appeared to be a common 
reaction for injecting drug users who at the time had many other stressors in their lives 
and did not view HCV as a priority. Some people reacted to HCV with the relief that it 
was not HIV, and viewed HCV as 'the lesser of the two evils' .  Others felt 'freaked 
out', 'shocked', 'stunned', 'devastated', 'frightened' and 'angry' and in some cases 
suicidal, often as a result of receiving limited or wrong information. In addition, some 
participants were under the impression that HCV was a fatal disease and that they were 
going to die, which created significant amounts of stress and anxiety for the individual 
and their families. 
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Table 1 
Responses Relating to Finding Out 
Way They Were Told " ... he said (the doctor) well look, we might as well 
test you for hep C ... and then I got a letter in the mail 
saying I was hep C positive ... that was it, that was it" 
(Pl l ) 
Information Told 
Reaction to Diagnosis 
Being 'Infectious' 
"I was told nothing except that it was a possibly fatal 
disease ... and he was disapproving and um no 
information what so ever actually" (P7) 
"It just freaked me out basically that I'd got it and 
there was no cure and I'd have to have 
treatment...um ... and it just totally stunned me 
yeah."(Pl) 
A positive diagnosis of hepatitis C immediately impacted on participants in that 
they were suddenly aware that they had a transmissible virus and were able to 'infect' 
other people. 'Being 'infectious' '  and the associated implications, was another theme 
that reflected participants' experiences of hepatitis C (Table 2). One of the biggest 
concerns for participants was the fear of transmitting the virus to somebody else and the 
constant worry of people coming into contact with their 'infectious blood'. 
The fear of transmission impacted considerably on many aspects of the 
participants' lives. Some people left their place of employment because they were 
afraid they were placing people at risk by staying at the workplace. Others reported that 
it had affected the relationship with their past or current partners by causing strain and 
tension, particularly when they cut themselves or when having sex. The fear of 
transmitting HCV to family members and particularly children resulted in a significant 
amount of stress and people described becoming extremely vigilant in keeping things 
clean and hygienic. In some cases, participants felt that they shouldn't go and visit 
family members with children because they didn't want to infect them. Being pregnant 
and transmitting to future children were also huge concerns for a number of both male 
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and female participants, even though they were aware of the relatively low risk 
associated with mother to child, or household transmission. 
Another impact associated with being ' infectious', was participants' sudden 
awareness of being different to everyone else because they had 'bad blood'. This 
seemed particularly relevant for those people who were regular blood donors and found 
out via the blood banks. A diagnosis ofHCV immediately meant that they could no 
longer donate blood, which led to feelings of exclusion or unworthiness. It was also 
reported that the simple event of cutting a finger, or the presence of even a minute 
amount of blood served as a reminder that they had this infectious virus and therefore 
were different to others. Some participants described feeling 'dirty and degraded' 
because they had this 'yucky type of virus' and in some cases felt isolated or like they 
were the 'odd one out'. 
Table 2 
Responses Relating To Being ' Infectious' 
Fear of Transmission "It's affected me and my partner on so many levels, 
it's stolen my sex life, hepatitis C has stolen it, what 
can I say .. .it took it away and still now I'm trying to 
get it back together" (P9). 
Bad Blood 
"I think there's a two year period where you don't 
know if you've passed it on to your child ... I hate to 
think that I've started a life off with that as well. 
(P IO). 
"I'm a qualified butcher and I can't work as one any 
more .. . I just stopped working because I was rather 
concerned .. .I'm just very, very careful." (P1 3) 
"Oh the other thing that upset me was that for all these 
years my husband had gone and given blood every six 
months, and when they told me I had hep C they 
scrubbed him off the blood bank and said we no 
longer want you"(P12). 
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Disclosure 
One of the areas that appeared to impact greatly on participants was the third 
main theme of 'disclosure'. Participants' views on disclosure were basically divided 
into two categories, those who did not disclose their HCV status to certain people, and 
those who did. The reasons why participants did not disclose were mainly due to the 
fear of a negative reaction, whereas those who felt they should disclose did so in order 
to keep people safe and to warn others of the risk of transmission (Table 3). 
The issue of deciding whether to disclose positive HCV status to someone was a 
significant source of stress and uncertainty for the majority of participants. There 
appeared to be a dilemma between telling someone due to the fear of transmission, and 
not telling them due to the possibility of negative consequences. This internal conflict 
was particularly highlighted in relation to telling current or future partners. While most 
participants felt that partners should know about their HCV status, disclosing posed the 
risk of rejection or some other negative reaction, which is closely linked to the stigma 
associated with hepatitis C. For some people, the fear of negative reactions had led to 
feelings of loneliness and isolation, as they were scared to get close to people. 
In addition to choosing whether or not to disclose, another source of stress 
involved knowing when to tell, how to tell and what to tell, and there was a lot of worry 
and confusion surrounding this issue. When asked about their experiences of 
disclosure, participants described both positive and negative reactions from different 
people. For example, some people found that telling friends or family members 
resulted in greater levels of support, while others experienced the ending of friendships 
or relationships as a result of disclosure. In addition, for the people who contracted 
HCV through injecting, disclosure would often mean revealing a history of injecting 
drug use, which in turn brought out feelings of shame and fears of being judged or 
rejected. 
One significant area of uncertainty and mixed feelings appeared to be whether or 
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not one should disclose to health professionals. While some participants felt it was their 
responsibility to inform doctors and dentists of their status, others felt that doctors, 
dentists and nursing staff should be protecting themselves anyway, and they shouldn't 
have to inform these people that they were HCV positive because of the stigma 
attached. Nevertheless, a number of participants were severely chastised and labelled as 
'irresponsible' by certain health professionals because they had not revealed their status 
immediately, and therefore had 'put all the staff at risk'. One participant described the 
experience as: 
" ... the doctor talked to me like a piece of shit cos I didn't volunteer that I 
had the virus ... they took my blood before I could tell them anyway and 
afterwards they came and asked me why I didn't tell them and how I got it 
and made me feel shit-house." (Pl )  
These experiences most commonly led to feelings of shame or anger and often 
increased already high levels of stress and anxiety for these participants. 
Table 3 
Responses Relating to Disclosure 
Fear of Negative Reaction "If there wouldn't be the possibility of negative 
reactions then you'd feel pretty comfortable ... but you 
know there would be negative reactions so you just 
keep it to yourself, you know?" (PS). 
Keeping People Safe 
" ... she wants to know but I don't know whether to tell 
her, I think she would accept it but I'm not sure .. .l've 
worked on this relationship and I don't want to lose 
it." (P4) 
"I always felt that why shouldn't I tell somebody if 
there's a chance they could get it from me, why 
shouldn't I tell them?" (P 12) 
"I do warn people, if I'm not asked directly and there 
is a concern for the other person, I'll always say 'yep 
I've got it' " (P13) 
Impacts of Hepatitis C 49 
Stigma 
One of the most salient themes to emerge among participants was the stigma 
associated with HCV and the impacts that were experienced as a result (see Table 4). 
All participants had either directly encountered the effects of stigma via discriminatory 
actions, or were acutely aware and subject to negative community attitudes linked with 
HCV. The range of settings in which participants experienced discrimination was wide, 
including the workplace, police, dentists and the church. However for these 
participants, discrimination was most often experienced within health care settings. 
Some examples included a doctor announcing the participant's HCV status in front of 
the rest of the hospital ward, the use of different medical equipment and postponing 
medical surgery due to positive hepatitis C status. 
Negative attitudes towards HCV were largely perceived as being related to the 
stigma associated with injecting drug users or the lack of education about the nature of 
HCV. Participants had experienced negative or judgemental attitudes from different 
people in the community, including family, friends and doctors, and described feelings 
of being 'looked down upon' or like 'everyone was judging' them. These negative 
attitudes were often associated with feelings of shame or low self-esteem, and in some 
cases led to the termination of friendships or reluctance in asking for health advice. 
The stigma associated with injecting drug users was particularly emphasised 
when participants talked about the distinction between whether they contracted the virus 
through injecting or blood transfusions. Blood transfusions were viewed more 
favourably, which was related to the idea that contracting the virus was beyond the 
person's control, whereas a diagnosis ofHCV through injecting was seen as being self­
inflicted and was more likely to be linked to negative attitudes and stigma. However 
participants from both groups reported being subject to the stereotypes of hepatitis C 
being a 'junkie's disease' and 'all people with hepatitis C must be drug users'. 
Participants also linked the stigma associated with HCV to the general 
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community's lack of education about the nature of the virus. This lack of knowledge 
led to unnecessary levels of fear about transmission, often as a result of seeing HIV and 
HCV as the same virus, therefore raising the same levels of fear and stigma. A number 
of participants thought that the key to reducing the level ofHCV related stigma in the 
community was to increase awareness and education surrounding hepatitis C so there 
would be less fear. 
Table 4 
Responses Relating to Stigma 
Experiences of Discrimination " ... the thing I remember is being prodded and 
poked ... a guy tried to unbutton my shirt with a pen 
because they didn't want to touch me" (P6). 
"Oh well, I mean he used to use a standard metal tray 
... but for me he'd bring out the disposable tray so he 
could throw it away, that sort of thing" (Pl l ). 
Stigma Related to Injecting "Well just that in hospital they told me you know 
you've got hep C and how did you get that...l just got 
treated like a junkie .. .in my case I'd rather keep quiet 
or say I got it through a blood transfusion, there's a 
stigma attached to it." (Pl )  
Negative Community Attitudes "Just the way they look down their nose at you, 
maybe not what they say but the delivery of what they 
say is more than just blatant and obvious ... you kind of 
squirm out and feel like scum" (P5). 
Lack of Education ''Now if the public could have some knowledge about 
transmission, they'd be less scared of us, there'd be 
less stigma" (P6) 
"What worries me the most is the people who don't 
understand the true facts about hepatitis C" (P13) 
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Symptoms 
A number of impacts were highlighted within the theme of' Symptoms', 
including the physical and psychological symptoms ofHCV, treatment and the 
ambiguity of the virus (Table 5). Only three participants reported having significant 
physical impacts as a result of hepatitis C, with by far the most common symptom being 
excessive fatigue. The experience of fatigue led to a number of physical restrictions, 
which in turn impacted on relationships and the ability to work. For example the 
physical nature of one participant's job led to a slower work rate, which eventually 
resulted in the loss of that job. 
A positive diagnosis of hepatitis C was also associated with a number of 
psychological impacts, particularly to do with self-concept. Some participants believed 
that living with HCV led to a more positive self-concept, by caring more about 
themselves and others. In some cases, contracting HCV gave participants a reason to 
move out of a lifestyle that they believed was no good for them. Others viewed 
themselves in a more negative light as a result of contracting HCV and reported feelings 
of guilt, anger and depression. It was interesting to note that for those who contracted 
HCV through injecting, having the virus was a constant reminder of their past and often 
accompanied feelings of shame, regret and self-blame. 
Stress, depression and anxiety also seemed to be related to participants' 
increased awareness of mortality, which was also linked to the ambiguous nature of the 
virus. Many participants were unsure if the symptoms they experienced were due to 
hepatitis C or from something else. The uncertainty surrounding the progression of 
HCV also appeared to be a factor that increased levels of stress, reflected by concerns 
that it was not known how much time was left before the hepatitis C 'got worse'. 
Four participants had been on anti-viral treatment and generally found that they 
experienced more physical and psychological side effects resulting from treatment, than 
from the virus itsel£ Side effects included nausea, fatigue, muscle aches, weight loss, 
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thinning hair, aggression and depression. All four participants described treatment as a 
negative experience with half of them having to cease treatment as the effects on their 
physical and psychological well being were too great. For the other two, although the 
side effects had a negative impact, treatment was seen as a form of hope that they could 
beat the virus. Treatment and the associated side effects also had huge implications for 
the participants' relationships, families and ability to work. Relationships had ended 
due to the significant strain that treatment had placed on them, and one person was no 
longer able to work, leading to financial implications. 
Table 5 
Responses Relating to Symptoms 
Physical "I've been totally drained .. .! would sleep a fair bit 
when I was working I'd just come home and go to bed 
and that was it...mainly I'm just physically stuffed" 
(P4) 
Psychological 
Ambiguity of Virus 
Treatment 
Dealing With It 
"Well it was just the stupidity of it, you know I was so 
careful and that one time I wasn't . .. fuck, every time I 
go to have a blood test I re-live that night. . .! don't 
know why I was so stupid" (P 1 )  
"I don't know whether next time I go for a liver test 
its going to be high and its going to affect me next 
year or it's not going to affect me at all' (P12) 
"Yeah the treatment is absolute agony, screws your 
head, stuffs up your relationships, but it gives you a 
light at the end of the tunnel..." (P4). 
A number of methods were used as a way of coping with living with hepatitis C 
and these were reflected within the theme of 'Dealing With It ' (Table 6). Participants 
had adjusted to living with HCV by attempting to gain some control over the virus. 
This was achieved in a number of ways which included educating themselves about 
HCV by finding out as much information as possible, and making positive lifestyle 
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changes such as reducing alcohol intake and eating healthy foods. However, it was 
mentioned that not drinking alcohol immediately restricted participants' social lives and 
led to negative consequences such as feeling like an outcast. 
Table 6 
Responses Relating to Dealing With It 
Gaining Control " ... we gathered up as much as we could (info) . . . so we 
learnt a lot about it that way and basically didn't panic 
as much" (P13) 
Don't Think About It 
Support from Others 
Part of a Journey 
"I probably don't think about it much any more .. .! just 
get on with life and enjoy it" (P12) 
" ... that's what the hepatitis group did for me, after the 
fourth week I felt like yeah, I'm a worthwhile person 
and I'm not alone .. "(P4) 
"Sometimes I just briefly sit and look at the 
experience and most times there is something there 
that I can learn from .. .it's helped uncover the true me" 
P9 
Some participants did not really dwell on the fact that they had hepatitis C and 
saw it as 'no big deal. ' Those people chose not to think about it and believed they 
should just get on with life and enjoy it. Support from others was seen as extremely 
important for some people and most support was given by family and friends. A 
number of people found the greatest support came from others who were also living 
with hepatitis C, whether it be people who were already in the participant's social circle, 
or through support groups. Finally, a number of people had developed a very positive 
view of hepatitis C and saw it as part of their life journey. Living with HCV was 
described as a learning experience, which had resulted in both personal and spiritual 
growth. 
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Discussion 
The purpose of this study was to examine the experiences of people living with 
HCV and explore the physical, psychological and social impacts of the virus. The 
:findings suggest that a positive HCV diagnosis results in a wide range of interrelated 
impacts which affect many aspects of an individual's life. Using a systems framework 
similar to that developed by Bronfenbrenner ( 1 979), it appears that HCV impacts on the 
personal, social and cultural environments of an individual. In addition, the results 
suggest that external factors within different levels of the system, also impact on an 
individual's experience of living with HCV (Figure 1 ). These findings support and 
further strengthen the socio-cultural view ofHCV reported by a number of researchers 
(Hepworth & Krug, 1999; Glacken et al, 2001 ). 
Cultural Level 
stigma 
Social Level 
education 
community awareness 
Figure 1 .  Participants' experiences of the physical, psychological and social impacts of 
HCV, using a systems perspective. 
Most research to date has focused on the impact ofHCV at what could be 
described as the personal level of the system, often reporting a significant decline in 
physical health or psychological well-being (Foster et al, 1 998; Loveday, Deakin & 
Neophyton, 1999). Interestingly, the physical impacts of HCV were not of great 
concern for the people in this study, with the majority of participants not experiencing 
_. 
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any physical symptoms at all. This finding is noteworthy given that most information 
and research available on HCV focuses primarily on the physical symptoms of the 
virus. Furthermore, the majority of information or advice that was given to the 
participants at the time of diagnosis by doctors' or other health professionals was 
largely to do with the physical effects ofHCV. Results from this study suggest that 
physical decline in health is not always an issue for people living with HCV. 
In contrast, the greatest impacts at a personal level for participants in this study 
appear to be psychological effects such as high levels of stress, feelings of anxiety, and 
negative self concept. However, it is interesting to note that this impact on 
psychological health does not only result directly from aspects of the virus itself, but 
also appears to be significantly influenced by external factors from within the 
individual's social and cultural environment. For example, the progression of the HCV 
virus is very ambiguous and the uncertainty that is associated with this can lead to high 
levels of stress and anxiety. However, factors at a social level such as the information 
given when diagnosed, reactions from family and friends, concerns about disclosure and 
transmission were more likely to directly influence individuals' levels of stress, anxiety 
and self concept. 
Research by Glacken et al (200 1 )  suggests that a HCV diagnosis is not an 
isolated, personal experience that impacts only on the individual's physical and 
psychological health, but one that immediately affects the lives of family and friends. 
The findings from the present study further support this research as it indicates that a 
positive HCV diagnosis has a far greater impact at a social level. Not only did 
participants report immediate effects on family and children due to fear of transmission, 
but were also very concerned about how HCV had affected their relationships, 
workplace and how to disclose to other people. 
External factors at a social level also appear to greatly influence an individual's 
experience of living with HCV and subsequent quality of life. It has been noted 
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previously that the reactions of family, partners, work colleagues and friends to a HCV 
diagnosis can significantly impact on the psychological health of the person with the 
virus. In addition, the level of support that an individual has in their social environment 
can positively impact on a person's experience ofliving with HCV. 
Another factor within the social environment that significantly impacts on an 
individual's experience of living with HCV is the quality of pre and post test 
counselling given by doctors or other health professionals. Pre-test and post test 
counselling is designed to reduce the impact of a positive diagnosis by providing 
sufficient information about possible outcomes, educating the person on the risk of 
transmission and ensuring that there is adequate support available (McCoy, Watson & 
Kosky, 1999). Unfortunately, this study supports findings by others who have 
suggested that the numbers of people who actually receive this counselling are minimal 
(Crossen et al., 1999; Burrows & Bassett, 1996). It is clear in this study that a large 
amount of unnecessary stress and anxiety was directly influenced by a lack of 
information, lack of preparation and misinformation given before and after the 
diagnosis. 
While a positive diagnosis ofHCV does not appear to impact on an individual's 
cultural environment per se, results from this study clearly suggest that external factors 
within the cultural environment significantly impact on the experience of living with 
HCV. Discrimination and stigma associated with HCV appear to be over-arching 
cultural factors which have extensive negative social and psychological impacts for 
people living with the virus. Stigma within the community appears to negatively impact 
on the individual's social networks including family, relationships, friends, work and 
can be directly related to the issue of disclosure. This in turn can lead to social isolation 
due to the fear of discrimination, and a negative view of the self due to rejection and 
being subject to stereotypes. It also seems evident that most people with HCV are 
subject to the stereotype of being a 'junkie' or 'druggie' , despite whether they 
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contracted it through injecting drug use or not, which suggests that there is a significant 
lack of community awareness and education surrounding the nature of HCV and how it 
is transmitted. 
Perhaps one of the more surprising findings was the extent to which people are 
subject to discrimination and judgmental attitudes within health care settings, a finding 
that has also been reported by a number of other researchers (Crofts, Louie & Loff, 
1997; Burrows & Bassett, 1996). One explanation for these negative attitudes by 
doctors and other health professionals could be a lack of training and education on HCV 
related issues. Nevertheless, this study further highlights previous findings which 
suggest that dealing with negative community attitudes and discrimination is often an 
everyday reality for people living with HCV (Ward, Colebome & Fort, 2000). 
The qualitative approach adopted in this study was the most appropriate method 
to seek understanding of personal experiences. It is acknowledged however that this 
method of inquiry results in some limitations of the study. The findings reported in this 
study reflect the experiences of the participants and cannot be generalised to every 
person who has hepatitis C. In addition, it is noted that analysis of qualitative data is 
somewhat subjective and reflects the author's interpretations of the participants' 
personal experiences. To further strengthen the findings of this study, future qualitative 
research is needed to explore the impacts ofHCV, perhaps using a less structured 
interview schedule. Despite these limitations, the value of this qualitative research is 
significant as it provides a rich and detailed insight into the range of social and cultural 
impacts associated with hepatitis C, which other methods may fail to recognise (Miles 
& Hubermann, 1994). 
Interestingly, the wide range of personal, social and cultural impacts reported in 
the present study, create a number of implications for health and helping professionals, 
the general community and makers of government policy. Providers of health care 
and/or support to people with HCV need to shift their focus from a view in which the 
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virus primarily impacts on physical health and psychological well being, and begin to 
adopt a more holistic approach towards the ways that HCV impacts on a person's life. 
There needs to be awareness that people living with HCV may have other concerns 
other than those that are health related and need support regarding issues such as 
disclosure, relationships, having children, transmission and dealing with discrimination. 
In addition, doctors and other health professionals should be aware of standard pre-test 
and post-test counselling guidelines and need to adhere to them, given the negative 
consequences that are associated with the lack of information or misinformation at the 
time of diagnosis. 
Furthermore, there are a number of serious implications for health professionals, 
as well as the general community, surrounding the significant amount ofHCV related 
stigma and discrimination that is experienced by many people living with the virus. 
Discrimination within healthcare settings particularly needs to be addressed as health 
professionals are viewed as the people to go to for support and advice in regards to 
health issues. If people living with HCV are reluctant to go to doctors for help or 
advice out of fear of being judged, the likelihood of people accessing these 
professionals is reduced and individual health and well being can be seriously 
compromised. Increased training for doctors and education for the community on HCV 
issues would potentially raise general awareness, reduce the fear associated with 
transmission and help dispel the stereotypes that often fuel judgemental attitudes and 
discriminatory behaviours. At a wider community level, government policy makers 
need to monitor anti-discrimination laws and make sure that policies are well known 
and adhered to in the community. 
Studies that examine the extent to which a positive HCV diagnosis impacts on 
various aspects of a person's life are relatively few and although important findings 
have been documented, there is still a great deal of scope for future research. An 
interesting next step from the present study would be to conduct a quantitative study 
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that assesses these results with a larger number of participants, to see if the findings 
could be generalised to a larger population. In addition, HCV related stigma and 
discrimination is clearly a significant issue for people living with the virus and ways to 
reduce judgemental attitudes and behaviour need to be addressed in future research. It 
would also be interesting to conduct a study that examines health professional' s 
attitudes and knowledge towards HCV related issues, given the extent of discrimination 
in health care settings. Finally, future research could also begin to focus on the 
potential impacts that a positive HCV diagnosis has on family members, partners and 
children of people who are living with the virus. 
In conclusion, it seems that a more holistic view of HCV needs to be adopted to 
provide adequate care and support for people living with the virus. It appears that the 
physical symptoms of the virus itself and potential decline in health are not necessarily 
perceived as the biggest impacts ofHCV. In contrast, the most distressing impacts can 
arise from the psychological and social effects ofliving with a stigmatised, infectious 
illness and dealing with the subsequent attitudes and reactions within the immediate 
social environment and wider community. 
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The following interview schedule can be used as a guide. The questions do not 
necessarily have to be asked in the presented order. 
A : Background 
1 .  To start with can you tell me your age, sex, and marital status. 
2. When do you believe you contracted hepatitis C? 
3. How do you believe you contracted hepatitis C? 
B: Impacts at Individual Level 
4. What symptoms, if any, have you experienced as a result of hepatitis C? 
Prompt questions include 
- Physical? 
- Psychological? 
5. How do you cope with these symptoms? 
6. Is there anything that you find you could do before, that you can't do now? 
7. Has having hepatitis C made a difference to the way you see yourself as a 
person? If so, in what way? 
C: Impacts at Social/Interpersonal Level 
8. What or who are your sources of support 
9. How does that help you? 
10. How do you think that hepatitis C has impacted on your life socially? 
Prompt questions include 
- family? 
- friends? 
- work? 
- relationships 
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D: Impacts at Cultural Level 
1 1 . Tell me about your experiences of learning that you have hepatitis C. 
Prompt questions include 
- How were you informed? 
- What information did the doctor/ health professional tell you? 
- How did you feel / react? 
12. Can you tell me about any other ways that hepatitis C has had an impact on 
your life? 
- discrimination? 
1 3. Is there any thing else you would like to share about your experience of 
living with hepatitis C? 
Appendix B 
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My name is Narel le Cockman and I am a volunteer at the Hepatitis C Counci l  
of WA, as wel l  as a fourth year university student at Edith Cowan 
University. I am currently conducting research with people who are l iving 
with hepatitis C and am particularly interested in the impacts that 
hepatitis C has on d ifferent aspects of a person's l ife. This research has 
been approved by the Edith Cowan School of Psycho logy Ethics Committee. 
The research wi l l  invo lve taking part in a tape recorded interview with 
myself, to share your experiences of l iving with hepatitis C. No names wi l l  
be recorded on  the tapes. The interview should take approximately one 
hour of your time. The aim of this research is to identify personal and 
social impacts of hepatitis C and wi l l  hopeful ly lead to further knowledge, 
better understanding and support for people l iving with hepatitis C. 
I understand that some issues wi l l  be potential ly sensitive for some people 
so please be assured that any information that you share during the 
interview wi l l  be held in the strictest confidence. An independent person 
wi l l  be helping out with the transcribing of the interviews, however your 
name wi l l  not be on these tapes. Responses and quotes may be used as part 
of a thesis but at no time wi l l  your name be reported. At the conclusion of 
this research, a report on the findings wi l l  be avai lable upon request. 
Your participation in this research is total ly voluntary. You are not obl iged 
to answer any particular question and may withdraw from the research at 
any time, without consequences. Referral to the Hepatitis C Information 
and Support Line and Crisis Care is also avai lable at any time. 
Please keep this information letter for your reference. If you have any 
questions or concerns about this research, you can contact myself (Narel le 
Cockman) on 0418 918 028, or my supervisor Lis Pike at the Schoo l of 
Psychology on 9400 5535. 
Appendix C 
Participant Consent Form 
Informed Consent 
Appendix C 67 
I (the participant) have read and understand the information sheet and any questions I 
asked were answered to my satisfaction. I agree to voluntarily participate in this 
research and realise that I may withdraw at any time. I also understand that the findings 
will be reported and I will in no way be identifiable. 
Participant. ___________ _ l)ate ______ _ 
Researcher l)ate ----------- -------
Appendix D 68 
Impacts of Hepatitis C 
How Has Hapatlli C lapactad On Y• Ufe 7 
lllla? Fatigue? 
llllallanrllipl .. 
DIICllnmtlon? 
I am a volunteer at the Hepatitis C Council ol WA and a 
loartb year university student. I am very interested 
in hearlna about your ezperlenees ol hepatitis C lor my 
research. D you are Interested in sbarlna your 
ezperlenees with me in a eonlldentlal tape recorded 
interview, I would love to bear lrom youm 
Please eontaet me, Narelle Coelcman on 9378 928•• 
